Researchers are exploring the use of biomimetic membrane-camouflaged nanoparticles to target glioblastoma, with some studies suggesting these nanoparticles can induce ferroptosis by promoting mitochondrial damage. The approach is part of a broader area of research into biomimetic nanomedicines for cancer therapy, with various studies investigating their potential for targeted treatment. The specific mechanisms and therapeutic applications of these nanoparticles are being investigated in multiple studies, with some focusing on their interaction with cellular processes such as autophagy and mitochondrial quality control.